110 related articles for article (PubMed ID: 2492200)
21. Protein kinase C interferes with Ni-mediated inhibition of human platelet adenylate cyclase.
Watanabe Y; Horn F; Bauer S; Jakobs KH
FEBS Lett; 1985 Nov; 192(1):23-7. PubMed ID: 4054315
[TBL] [Abstract][Full Text] [Related]
22. NAD+-mediated stimulation of adenylate cyclase in cardiac membranes.
Feldman AM; Levine MA; Baughman KL; Van Dop C
Biochem Biophys Res Commun; 1987 Feb; 142(3):631-7. PubMed ID: 2950854
[TBL] [Abstract][Full Text] [Related]
23. Evidence for regulation of human platelet adenylate cyclase by phosphorylation. Inhibition by ATP and guanosine 5'-[beta-thio]diphosphate occur by distinct mechanisms.
Wadman IA; Farndale RW; Martin BR
Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):621-30. PubMed ID: 1905923
[TBL] [Abstract][Full Text] [Related]
24. Isolation of an avian erythrocyte protein possessing ADP-ribosyltransferase activity and capable of activating adenylate cyclase.
Moss J; Vaughan M
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3621-4. PubMed ID: 211502
[TBL] [Abstract][Full Text] [Related]
25. Target proteins for arginine-specific mono(ADP-ribosyl) transferase in membrane fractions from chick skeletal muscle cells.
Huang HY; Zhou H; Huiatt TW; Graves DJ
Exp Cell Res; 1996 Jul; 226(1):147-53. PubMed ID: 8660950
[TBL] [Abstract][Full Text] [Related]
26. Platelet alpha-2 adrenoceptor-mediated primary aggregation and adenylate cyclase inhibition in depressed patients.
Karege F; Bovier P; Hilleret H; Gaillard JM
Lancet; 1993 Apr; 341(8851):1029. PubMed ID: 8096917
[No Abstract] [Full Text] [Related]
27. Determination of G-protein levels, ADP-ribosylation by cholera and pertussis toxins and the regulation of adenylyl cyclase activity in liver plasma membranes from lean and genetically diabetic (db/db) mice.
Palmer TM; Houslay MD
Biochim Biophys Acta; 1991 Oct; 1097(3):193-204. PubMed ID: 1932144
[TBL] [Abstract][Full Text] [Related]
28. Platelet adenylate cyclase and phospholipase C are affected differentially by ADP-ribosylation. Effects on thrombin-mediated responses.
Banga HS; Walker RK; Winberry LK; Rittenhouse SE
Biochem J; 1988 May; 252(1):297-300. PubMed ID: 3138970
[TBL] [Abstract][Full Text] [Related]
29. Heparin and heparinoids impair adrenaline and platelet-activating factor but not thrombin-induced inhibition of adenylate cyclase and stimulation of GTP hydrolysis in human platelet membranes.
Willuweit B; Aktories K
Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):354-8. PubMed ID: 2969081
[TBL] [Abstract][Full Text] [Related]
30. Interaction of stable prostaglandin endoperoxide analogs U46619 and U44069 with human platelet membranes: coupling of receptors with high-affinity GTPase and adenylate cyclase.
Avdonin PV; Svitina-Ulitina IV; Leytin VL; Tkachuk VA
Thromb Res; 1985 Oct; 40(1):101-12. PubMed ID: 3003958
[TBL] [Abstract][Full Text] [Related]
31. Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells.
Cruciani RA; Dvorkin B; Morris SA; Crain SM; Makman MH
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):3019-23. PubMed ID: 8385355
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of fluoride on adenylate cyclase activity and guanine nucleotide regulation of agonist high-affinity receptor binding.
Stadel JM; Crooke ST
Biochem J; 1988 Aug; 254(1):15-20. PubMed ID: 2845943
[TBL] [Abstract][Full Text] [Related]
33. A possible role for mono (ADP-ribosyl) transferase in the signalling pathway mediating neutrophil chemotaxis.
Allport JR; Donnelly LE; Kefalas P; Lo G; Nunn A; Yadollahi-Farsani M; Rendell NB; Murray S; Taylor GW; MacDermot J
Br J Clin Pharmacol; 1996 Jul; 42(1):99-106. PubMed ID: 8807150
[TBL] [Abstract][Full Text] [Related]
34. Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase.
Zavoico GB; Feinstein MB
Biochem Biophys Res Commun; 1984 Apr; 120(2):579-85. PubMed ID: 6329175
[TBL] [Abstract][Full Text] [Related]
35. Vasopressin inhibition of human platelet adenylate cyclase: variable responsiveness between donors and involvement of a G-protein different from Gi.
Vittet D; Mathieu MN; Cantau B; Chevillard C
Eur J Pharmacol; 1988 Jun; 150(3):367-72. PubMed ID: 3138140
[TBL] [Abstract][Full Text] [Related]
36. Decrease in epinephrine-induced attenuation of platelet adenylate cyclase activity in depressed patients: relation with plasma electrolytes.
Karege F; Bovier P; Widmer J; Gaillard JM; Tissot R
Neuropsychobiology; 1992; 26(3):129-35. PubMed ID: 1338221
[TBL] [Abstract][Full Text] [Related]
37. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
[TBL] [Abstract][Full Text] [Related]
38. The stimulatory guanine-nucleotide regulatory unit of adenylate cyclase from bovine cerebral cortex. ADP-ribosylation and purification.
Neer EJ; Wolf LG; Gill DM
Biochem J; 1987 Jan; 241(2):325-36. PubMed ID: 3109373
[TBL] [Abstract][Full Text] [Related]
39. Thrombin-like inhibitory action of trypsin and trypsin-like proteases on human platelet adenylate cyclase.
Jakobs KH; Grandt R
Eur J Biochem; 1988 Feb; 172(1):255-60. PubMed ID: 3278907
[TBL] [Abstract][Full Text] [Related]
40. Uncoupling by proteolysis of alpha-adrenergic receptor-mediated inhibition of adenylate cyclase in human platelets.
Ferry N; Adnot S; Borsodi A; Lacombe ML; Guellaën G; Hanoune J
Biochem Biophys Res Commun; 1982 Sep; 108(2):708-14. PubMed ID: 6293500
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
